Assessing Safety & Efficacy in the Dose Escalation of MYTX-011 Phase 1 KisMET-01 Study

  • Unveiling efficacy data of MYTX-011 from Phase 1 KisMET-01 study
  • Detailing safety and tolerability profile data from expanded patient cohorts
  • Reflecting on the reasoning and rationale for MYTX-011 dose escalation